This week’s roundup of New England deals includes companies working on vocal cord repair, cancer stem cells, database software, IT services, and drug counterfeiting prevention.

—Prolific MIT professor and inventor Bob Langer is working on a new project with a Harvard University surgeon that’s aiming to repair damaged vocal cords. The vibrating gel they’re developing has attracted funding from The Who’s lead singer Roger Daltrey, Aerosmith’s Steven Tyler, and actress Julie Andrews, and could help treat aging singers as well as throat cancer patients.

—MindShift Technologies, a Waltham-based provider of cloud, data center, and other IT services for businesses, was acquired for $167 million by Best Buy (NASDAQ: BBY). The retailer said the acquisition helps it expand its IT services offerings for small and mid-sized businesses. MindShift, meanwhile, will keep its name, leadership team, and all 500 employees.

—-Late last month, Lebanon, NH-based PharmaSecure raised $3.9 million in a round of funding led by Innovation Endeavors—the former Google CEO Eric Schmidt—with participation from Gray Ghost Ventures, Healthtech Capital and TEEC Angel Fund. My colleague Arlene took a closer look at the four-year-old startup, which is developing drug packaging technology to prevent counterfeiting in markets like India.